GSK plc Files Form 6-K on Share Transactions
Ticker: GSK · Form: 6-K · Filed: Apr 13, 2026
Sentiment: neutral
Topics: share-transaction, 6-K, sec-filing
TL;DR
GSK plc filed a 6-K on 4/13/26 about share transactions.
AI Summary
On April 13, 2026, GSK plc filed a Form 6-K with the SEC, reporting a transaction involving its own shares. The filing, with SEC Accession No. 0001654954-26-003420, was accepted on the same date. The document type is a report of a foreign issuer.
Why It Matters
This filing indicates GSK plc is actively managing its share capital, which can impact stock value and investor perception.
Risk Assessment
Risk Level: low — This is a routine filing reporting on share transactions, not indicating significant new risks.
Key Players & Entities
- GSK plc (company) — Filer
- 0001131399 (company) — CIK number for GSK plc
- 0001654954-26-003420 (document) — SEC Accession Number
- April 13, 2026 (date) — Filing Date and Period of Report
FAQ
What type of transaction is reported in the Form 6-K filed by GSK plc?
The Form 6-K reports a 'TRANSACTION IN OWN SHARES'.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 0001654954-26-003420.
When was this Form 6-K filing accepted by the SEC?
The filing was accepted on April 13, 2026.
What is the CIK number for GSK plc?
The CIK number for GSK plc is 0001131399.
What is the SIC code listed for GSK plc?
The SIC code listed is 2834 for Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 13, 2026 regarding GSK plc (GSK).